Immune-Modulators and Thyroid Function in Oncological Patients with Hashimoto 'S Thyroiditis

Hashimoto's thyroiditis (HT) is a form of chronic lymphocytic thyoriditis, of autoimmune origin and multiple physiopathogenic pathways, which may or may not be associated with other autoantibody diseases, both endocrinological (P.A.S.) and non-endocrinological (M.A.S.). Likewise, HT can coincide -in the same patient- with very varied oncological pathologies, with which it can interact in a usually negative way. In this article, the benefit achieved in cancer patients who also had HT is evaluated through the use of immune-modulators.